Belite Bio (BLTE) Debt Ratio (2021)
Belite Bio (BLTE) posted quarterly Debt Ratio of 0.0 for Q4 2021.
Powered by 
Analysis
Belite Bio (BLTE) Debt Ratio (2021) Analysis & Trends
Belite Bio's Debt Ratio history runs 1 years deep, the most recent figure standing at 0.0 for Q4 2021.
- In Q4 2021, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Dec 2021 stood at 0.0 (changed N/A YoY), while the FY2021 annual figure was 0.0, changed N/A from the prior year.
- Debt Ratio for Q4 2021 stood at 0.0.
- The five-year high for Debt Ratio was 0.0 in Q4 2021, with the low at 0.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 0.05 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 0.12 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 0.47 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 0.26 |
| 10 | Belite Bio | 6.26 Bn | 6.26 Bn | - | - |